Asset Details
Do you wish to reserve the book?
Systematic review of human papillomavirus prevalence in invasive penile cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Systematic review of human papillomavirus prevalence in invasive penile cancer
Do you wish to request the book?
Systematic review of human papillomavirus prevalence in invasive penile cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Systematic review of human papillomavirus prevalence in invasive penile cancer
2009
Overview
Objective Type-specific prevalence data of human papillomavirus (HPV) DNA in penile carcinoma are needed to determine the potential impact of HPV prophylactic vaccines, assuming demonstrated efficacy in men. Methods A review was conducted using search terms including HPV and penile cancer. Studies using polymerase chain reaction (PCR) assays for HPV DNA detection in invasive penile carcinoma were included. Results A total of 1,266 squamous cell carcinoma (SCC) cases contributed data from 30 studies. The number of SCC was similar in Europe (28.2%), North America (27.6%), South America (23.9%) and Asia (20.4%). All SCC were histologically confirmed with biopsies for DNA detection. Most commonly used PCR primers were type-specific (35.2%), and combination PCR (18.2%). HPV prevalence was 47.9%, ranging from 22.4% in verrucous SCC to 66.3% for the basaloid/warty subtypes. HPV16 (30.8%), HPV6 (6.7%) and HPV18 (6.6%) were the most prevalent types. HPV16 and/or HPV 18 prevalence was 36.7%. Conclusions HPV DNA was detected in half of SCC, with HPV16 being the most common type. If proven efficacious in men, prophylactic vaccines targeting carcinogenic types HPV16 and 18 could potentially reduce approximately one-third of incident SCC.
Publisher
Dordrecht : Springer Netherlands,Springer,Springer Netherlands,Springer Nature B.V
Subject
/ Biomedical and Life Sciences
/ Biopsies
/ Biopsy
/ Carcinoma, Squamous Cell - pathology
/ Carcinoma, Squamous Cell - virology
/ DNA, Viral - isolation & purification
/ Human papillomavirus 16 - isolation & purification
/ Human papillomavirus 18 - isolation & purification
/ Human papillomavirus 6 - isolation & purification
/ Humans
/ Male
/ North America - epidemiology
/ Oncology
/ Papillomaviridae - classification
/ Papillomaviridae - isolation & purification
/ Papillomavirus Infections - epidemiology
/ Papillomavirus Infections - virology
/ Penis
/ South America - epidemiology
/ Vaccines
